AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01530-06v1
51/10/3699    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torrico, M.
Right arrow Articles by Prieto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torrico, M.
Right arrow Articles by Prieto, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2007, p. 3699-3706, Vol. 51, No. 10
0066-4804/07/$08.00+0     doi:10.1128/AAC.01530-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Influence of TEM-1 ß-Lactamase on the Pharmacodynamic Activity of Simulated Total versus Free-Drug Serum Concentrations of Cefditoren (400 Milligrams) versus Amoxicillin-Clavulanic Acid (2,000/125 Milligrams) against Haemophilus influenzae Strains Exhibiting an N526K Mutation in the ftsI Gene{triangledown}

M. Torrico,1 L. Aguilar,1 N. González,1 M. J. Giménez,1 O. Echeverría,1 F. Cafini,1 D. Sevillano,1 L. Alou,1 P. Coronel,2 and J. Prieto1*

Microbiology Department, School of Medicine, University Complutense, Avda. Complutense s/n, 28040 Madrid, Spain,1 Scientific Department, Tedec-Meiji Farma SA, Ctra. M-300, Km. 30,500, 28802 Alcalá de Henares, Madrid, Spain2

Received 5 December 2006/ Returned for modification 9 April 2007/ Accepted 23 July 2007

The aim of this study was to explore bactericidal activity of total and free serum simulated concentrations after the oral administration of cefditoren (400 mg, twice daily [bid]) versus the oral administration of amoxicillin-clavulanic acid extended release formulation (2,000/125 mg bid) against Haemophilus influenzae. A computerized pharmacodynamic simulation was performed, and colony counts and ß-lactamase activity were determined over 48 h. Three strains were used: ampicillin-susceptible, ß-lactamase-negative ampicillin-resistant (BLNAR) (also resistant to amoxicillin-clavulanic acid) and ß-lactamase-positive amoxicillin-clavulanic acid-resistant (BLPACR) strains, with cefditoren MICs of ≤0.12 µg/ml and amoxicillin-clavulanic acid MICs of 2, 8, and 8 µg/ml, respectively. Against the ampicillin-susceptible and BLNAR strains, bactericidal activity (≥3 log10 reduction) was obtained from 6 h on with either total and free cefditoren or amoxicillin-clavulanic acid. Against the BLPACR strain, free cefditoren showed bactericidal activity from 8 h on. In amoxicillin-clavulanic acid simulations the increase in colony counts from 4 h on occurred in parallel with the increase in ß-lactamase activity for the BLPACR strain. Since both BLNAR and BLPACR strains exhibited the same MIC, this was due to the significantly lower (P ≤ 0.012) amoxicillin concentrations from 4 h on in simulations with ß-lactamase positive versus negative strains, thus decreasing the time above MIC (T>MIC). From a pharmacodynamic point of view, the theoretical amoxicillin T>MIC against strains with elevated ampicillin/amoxicillin-clavulanic acid MICs should be considered with caution since the presence of ß-lactamase inactivates the antibiotic, thus rendering inaccurate theoretical calculations. The experimental bactericidal activity of cefditoren is maintained over the dosing interval regardless of the presence of a mutation in the ftsI gene or ß-lactamase production.


* Corresponding author. Mailing address: Microbiology Department, School of Medicine, University Complutense, Avda. Complutense s/n, 28040 Madrid, Spain. Phone: 34 91 3941508. Fax: 34 91 3941511. E-mail: jprieto{at}med.ucm.es

{triangledown} Published ahead of print on 30 July 2007.


Antimicrobial Agents and Chemotherapy, October 2007, p. 3699-3706, Vol. 51, No. 10
0066-4804/07/$08.00+0     doi:10.1128/AAC.01530-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.